Introduction
Tumor necrosis factor (TNF) plays a central role in diverse immune and in¯ammatory processes . Although, physiologically, TNF actions are bene®cial, it is clear that aberrations in TNF production in vivo may be pathological. The potential of TNF to induce chronic in¯ammatory disease has been exempli®ed in animal models, where deregulation of its production leads to the development of various pathologies . Conversely, interleukin-10 (IL-10) has emerged as a macrophage deactivator competent to suppress the expression of in¯ammatory mediators as well as the macrophages' ability to support accessory functions to adaptive immunity (for review see Moore et al., 1993) . The antiin¯ammatory potential of IL-10 has been repeatedly demonstrated in vivo, in preventing endotoxemia (Gerard et al., 1993; Marchant et al., 1994) and suppressing the development of intestinal in¯ammation (Kuhn et al., 1993) . In particular, an indication of a homeostatic TNF/ IL-10 axis against in¯ammatory bowel disease (IBD) is provided by the fact that mice de®cient in IL-10, or in macrophage signaling molecules that mediate IL-10 receptor signals, overproduce TNF and develop IBD (Kuhn et al., 1993; Takeda et al., 1999) . Activation of macrophages by lipopolysaccharide (LPS) results in the rapid production of both TNF and IL-10, with similar kinetics (Marchant et al., 1994) . However, the mechanism by which IL-10 suppresses TNF expression remains elusive. It is possible that IL-10 may affect the same pathways that are required for LPS-induced TNF production (Geng et al., 1994; Wang et al., 1995) . However, there is a great degree of contradictory data as to what level(s) IL-10 exerts its inhibitory action (Bogdan et al., 1991 (Bogdan et al., , 1992 de Waal et al., 1991; Wang et al., 1995; Brown et al., 1996; Kishore et al., 1999) .
Homeostatic control of TNF biosynthesis is exerted at multiple levels and proceeds through a multitude of signals. For example, binding of LPS to its Toll-receptor complex on macrophages transmits signals through tyrosine kinases, protein kinase C, NFkB, and the mitogen-and stress-activated protein kinases (MAPK/ SAPK) ERK, JNK and p38 (reviewed by Beutler, 2000) . These signals may affect TNF gene expression directly, at the level of transcription (Collart et al., 1990) , splicing (Osman et al., 1999) , mRNA stability and translation (Carballo et al., 1998; Kontoyiannis et al., 1999) , and protein processing (Peschon et al., 1998) . We have recently demonstrated that the AU-rich elements (ARE) residing in the 3¢UTR of TNF mRNA are important in controlling message stability and translational activation . The latter appears to rely on the activity of the MAPK/SAPK pathways . Although data on TNF ARE binding factors remain scarce, recent evidence indicated that the prototype member of a zinc ®nger family of RNA binding proteins, tristetraprolin (TTP), has the capacity to modulate TNF expression in vivo by destabilizing TNF mRNA in an ARE-dependent fashion (Carballo et al., 1998) . Whether TTP exclusively modulates TNF mRNA stability, and with what signaling requirements, remains to be demonstrated.
In this report we demonstrate that, in mouse macrophages, IL-10 exerts its anti-in¯ammatory and immunosuppressive action mainly by targeting ARE-mediated Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology The EMBO Journal Vol. 20 No. 14 pp. 3760±3770, 2001 translation of the TNF message through modulation of activating p38/SAPK signals. Aberrations in TNF production due to the absence of IL-10 function in mutant mice are shown here to be causal for intestinal in¯ammation, indicating that correct regulation of the IL-10/TNF axis is of physiological signi®cance to intestinal immune homeostasis.
Results
Absence of TNF attenuates development of IBD in IL-10-de®cient mice Examination of TNF production in LPS-induced macrophages from normal or IL-10-de®cient mice demonstrated that TNF was overexpressed in the latter ( Figure 1D ). To substantiate whether a defective TNF/IL-10 axis is a general criterion for the development of intestinal in¯am-mation, we assessed the role of TNF in the development of enterocolitis in IL-10-de®cient mice by generating doublemutant (Il-10 ±/± Tnf ±/± ) mice. As shown in Figure 1B , the macroscopic disease developing in Il-10 ±/± and Il-10 ±/± Tnf +/± mice was similar, and resulted in lethality for 40±50% (n = 27 and 24 mice, respectively) of the animals by the age of 10 weeks. Clinical symptoms included gradual weight loss ( Figure 1A ) and an increased incidence of colorectal prolapses (in~70±80% of mice examined). In sharp contrast, 80% (18/21) of Il-10 ±/± Tnf ±/± mice showed no symptoms of macroscopic disease and appeared normal throughout the period examined (20 weeks). However, three out of the 21 double-homozygous mice developed clinical symptoms similar to those presented by control groups. Histological evaluation of the large intestine of the control groups revealed moderate to severe in¯ammatory occurrences (Table I) . In sharp contrast, colitis was completely prevented in 77% of the double-homozygous mice ( Figure 1C ; Table I ). However, in the three diseased as well as in two asymptomatic Il-10 ±/± Tnf ±/± mice, the histological hallmarks of colitis developed with differential onset. These results demonstrate that TNF is dominantly involved in the development of colitis in IL-10-de®cient mice.
We next tested in the Tnf DARE mouse whether defective IL-10 production could be associated with the development of IBD in this system. Interestingly, TNF overexpression in Tnf DARE mice is accompanied by exacerbated production of IL-10 both in vivo and in vitro ( Figure 1E and F). Thus, IL-10 production is enhanced in Tnf DARE mice, yet its action appears ineffective in suppressing the high TNF load.
IL-10 inhibits TNF production by macrophages at multiple levels We examined in detail the effect of IL-10 on LPSstimulated TNF production by murine macrophages. Since IL-10 production coincides with TNF production ( Figure 1E and F), we hypothesized that, physiologically, IL-10 targets TNF expression concurrently with the LPS signals. IL-10 inhibited, in a dose-dependent manner, the secretion of TNF by thioglycolate-elicited peritoneal macrophages (TEPM) and bone marrow-derived (BMDM) macrophage cultures, reaching a maximal value of >80% inhibition at 5 ng (Figure 2A ). At the same dose, IL-10 also reduced the levels of LPS-induced transmembrane TNF protein accumulation by 80±90%, as indicated by¯ow cytometry ( Figure 2B ). In contrast, IL-10 reduced the levels of steady-state TNF mRNA by <20±30% ( Figure 2C ). To verify whether this reduction in TNF mRNA levels occurred due to a decrease in transcription rates or to a decrease in message stability, we measured the effect of IL-10 on the decay of TNF mRNA in the presence of actinomycin D added 1 h following LPS stimulation. Remnant TNF mRNA levels were measured at 15, 30 and 60 min intervals using northern analysis ( Figure 2D ). From the estimated half-lives (TEPM: ±IL-10, t 1/2 = 17.8 min; +IL-10, t 1/2 = 19 min; BMDM: ±IL-10, t 1/2 = 26 min; +IL-10, t 1/2 = 22 min), it is evident that IL-10 does not signi®cantly affect TNF mRNA decay in mouse macrophages. Similar conclusions were reached following transcriptional arrest at 3 and 6 h post-stimulation (data not shown). Therefore, following LPS stimulation, the IL-10-induced reduction in TNF mRNA levels probably re¯ects a change in TNF transcription. Consequently, the additional~60% reduction in the levels of soluble and transmembrane TNF protein may result from a direct suppressive effect of IL-10 on TNF mRNA translation. To verify this hypothesis, we fractionated cytoplasmic extracts from LPS-and LPS/IL-10-stimulated TEPM over sucrose gradients to compare the polysome pro®les of TNF and GAPDH mRNAs ( Figure 2E ). A clear reduction in the number of polysomal fractions containing TNF mRNA in IL-10-treated macrophages (±IL-10: 3.75 6 0.95; +IL-10: 1.5 6 0.57; p = 0.006; n = 4) was noted. In contrast, the fraction of GAPDH transcripts associated with polysomes was not different in LPS-and LPS + IL-10-treated macrophages ( Figure 2E ). Overall, our data demonstrate that IL-10 inhibits macrophageproduced TNF primarily at the level of its mRNA translation.
Effective inhibition of TNF production by IL-10 requires the presence of TNF AU-rich elements To elucidate whether IL-10-mediated inhibition of TNF gene expression required the 3¢ARE, we examined the effect of IL-10 on TNF expression in Tnf DARE macrophages. TEPM and BMDM were isolated from a diseasefree TnfRI ±/± background to eliminate the possible effects of chronic in¯ammation occurring in the original Tnf DARE mice. IL-10 treatment of TnfRI ±/± Tnf +/+ macrophages resulted in a reduction of LPS-induced TNF mRNA accumulation, polysomeassociated TNF mRNA (data not shown) and TNF protein secretion ( Figure 3A ) similar to those observed in Tnf +/+ macrophages. TnfRI ±/± Tnf DARE/DARE macrophages produce 3-fold higher levels of TNF mRNA than TnfRI ±/± Tnf +/+ macrophages . Nonetheless, similarly to the Tnf +/+ controls, TnfRI ±/± Tnf DARE/DARE macrophages showed a decrease in mutant mRNA values of~30% ( Figure 3C ). Actinomycin D treatment of TnfRI ±/± Tnf DARE/DARE macrophages ( Figure 3D ) indicated that TNF DARE mRNA stability, albeit higher than that of the wild-type TNF mRNA, remained unaffected in the presence of IL-10 (TEPM: ±IL-10, t 1/2 = 54.6 min; +IL-10, Fig. 1 . Evidence for a defective TNF/IL-10 axis in IL-10 knockout and TNF DARE mutant mice. (A) Weight distribution and (B) cumulative percent survival of Il-10 ±/± Tnf ±/± and control mice. (C) Representative photomicrographs (3200) of the proximal colon of Il-10 ±/± Tnf ±/± from: (i) 8-week-old Il-10 ±/± Tnf +/± control mice showing prominent transmural in¯ammation (arrows), epithelial cell hyperplasia and goblet cell loss; (ii) 14-week-old Il-10 ±/± Tnf ±/± colon showing normal epithelial integrity; (iii) 12-week-old Il-10 ±/± Tnf ±/± asymptomatic mouse showing mild signs of submucosal in¯ammation (asterisk); (iv) 12-week-old Il-10 ±/± Tnf ±/± diseased mouse showing severe in¯ammation. (D) Kinetics of TNF protein accumulation (upper) and production per hour (lower) in Il-10 +/+ and Il-10 ±/± TEPM following LPS stimulation in vitro. TNF and IL-10 protein levels in collected supernatants were determined by ELISA. Results shown as mean 6 SD values from ®ve cultures/group. (E) Kinetics of TNF and IL-10 protein production in Tnf +/+ (closed circles) and Tnf DARE/+ (open circles) mice following LPS challenge in vivo. Mice were challenged with 100 mg/ml LPS intraperitoneally and subsequently exsanguinated via cardiac puncture at the indicated time points. TNF and IL-10 protein levels in sera were determined by ELISA. Results shown as mean 6 SD values from four mice/time point. (F) Kinetics of TNF and IL-10 in Tnf +/+ (closed circles) and Tnf DARE/+ (open circles) TEPM and following LPS stimulation, in vitro. TEPM were cultured as before and subsequently stimulated with LPS (1 mg/ml) for 12 h. dose of 10 ng/ml ( Figure 3A ). The levels of protein reduction were comparable to the decrease in TNF mRNA accumulation ( Figure 3C ). The inability of IL-10 to suppress protein production ef®ciently in TnfRI ±/± Tnf DARE/DARE macrophages was speci®c, since the level of nitric oxide (NO) production following LPS stimulation was inhibited equally in both wild-type and mutant macrophages ( Figure 3B ). Cytoplasmic extract fractionation and polysomal analysis revealed a wide distribution of TNF DARE mRNA in the polysomal fractions, which was Table I . Effects of TNF absence on the incidence and severity of colitis in IL-10 ±/± mice Genotype No. of mice affected Disease score distribution a Mean disease score (0±20) a 0 >0±5 >5±10 >10±15 >15±20
Il-10 ±/± 14/14 (100%)² 0 0 4 7 3 13.1 6 4.1* Tnf ±/± 0/5 (0%) 5 0 0 0 0 nil Il-10 ±/± Tnf +/± 13/15 (87%)²² 2 2 3 6 3 10.6 6 5.9** Il-10 ±/± Tnf ±/± 5/21 (23%) 16 2 0 1 2 3.47 6 5.71
a Mean severity of colonic lesions in affected mice; assessment as in Materials and methods. Data are represented as mean 6 SD. *Denotes a signi®cant difference to the corresponding test group score (assessed by using unpaired Student's t-test): *p = 0.002; **p = 0.00005. ²Denotes a signi®cant difference to the corresponding test group score (assessed by using two-tailed Fisher's exact test): ²p = 0.00018; ²²p = 0.00000324. IL-10 regulates TNF translation by controlling p38 MAPK not signi®cantly altered in the presence of IL-10 (±IL-10: 4.33 6 0.57; +IL-10: 4.01 6 1.0; n = 3) ( Figure 3E ). These results demonstrate that in the absence of an intact TNF 3¢ARE, IL-10 cannot inhibit LPS-induced translation, and suggest that IL-10-mediated suppression of TNF translation requires an intact ARE.
The ARE binding protein TTP is not required for the IL-10-mediated inhibition of TNF production We have compared the kinetics of TNF protein production from LPS-stimulated wild-type, TTP-de®cient and Tnf DARE BMDM. As has been described previously (Carballo et al., 1998; Kontoyiannis et al., 1999) , both TTP ±/± and Tnf DARE BMDM overproduce TNF following LPS stimulation relative to wild-type cultures. This correlated with an increase in the levels of TNF produced per hour by TTP ±/± and, strikingly more so, by Tnf DARE macrophages ( Figure 4A ). Apart from the difference in the level of TNF protein produced, a difference in the duration of TNF production between the TTP ±/± and the Tnf DARE macrophages could be revealed upon normalization of maximal values ( Figure 4A ). Wild-type TNF is produced for 5 h, whereas TTP ±/± TNF is produced for 7 h and Tnf DARE TNF for >9 h. Comparison of the corresponding mRNA values showed a similar increase in TNF mRNA accumulation in LPS-stimulated TTP ±/± and Tnf DARE BMDM relative to wild-type values, indicating a comparable effect of both mutations on TNF mRNA stability (data not shown). Thus, the difference in TNF protein production between TTPand TNF ARE-de®cient macrophages lies in the added modulation of TNF mRNA translation by the ARE. This was con®rmed by the use of SB203580, which is known to inhibit the translation of TNF mRNA in a TNF AREdependent manner. SB203580 was as ef®cient in blocking TNF production by TTP ±/± BMDM as it was in the case of TTP +/+ macrophages ( Figure 4B ). Similarly, IL-10-mediated suppression of TNF production, although minimal in the absence of TNF ARE, occurred normally in TTP ±/± as well as control macrophages ( Figure 4B ). Taken together, these results show that TTP is not required for the AREdependent modulation of TNF mRNA translation in macrophages, indicating differential organization of TNF ARE-mediated stability and translational controls.
Reduced p38/SAPK activation in the presence of IL-10 in LPS-stimulated macrophages The p38, JNK and ERK MAPK/SAPK pathways have previously been demonstrated to modulate TNF biosynthesis (Lee et al., 1994; Swantek et al., 1997; Kontoyiannis et al., 1999; Srivastava et al., 1999; Dumitru et al., 2000) . A paradigm of cross-talk between signals activated by the IL-10 receptor and MAPK/SAPK has also been demonstrated previously (Kallunki et al., 1994; Niiro et al., 1998; Turkson et al., 1999) . However, other reports (reviewed by Donelly et al., 1999) have not been able to reproduce an effect of IL-10 on these signaling modules. We examined the effect of IL-10 on the LPS-induced activation of ERK, JNK and p38 MAPK in TEPM, and the mouse macrophage cell line RAW 264.7, by detecting the corresponding native and phosphorylated forms via western blotting. As can be readily seen in Figure 5A , IL-10 inhibited the LPSinduced phosphorylation of p38 MAPK by 90% in TEPM and by 50% in RAW 264.7 macrophages, while the levels of the native form of this protein remained unaltered. In contrast, no reduction was observed in the levels of the phosphorylated forms of JNK1/2 ( Figure 5B ) and ERK1/2 (not shown). These results suggest that IL-10 interferes with p38 signaling at the level of its phosphorylation by upstream kinases, but not at the level of p38 abundance. Kollias and M.Gaestel, in preparation) . Macrophages from these mice show a pattern of TNF production similar to that observed in TNF DARE macrophages, indicating that MK2 targets TNF ARE. We further examined whether the absence of MK2 signals interferes with IL-10 targeting of TNF production. Exposure of LPS-stimulated mk2 ±/± TEPM to IL-10 reduced TNF protein production by 30±40% instead of 80% in mk2 +/+ macrophages ( Figure 6A ). In addition, the LPS-induced, polysomeassociated TNF mRNA pro®le in MK2-de®cient TEPM, although it appears lower than in LPS-induced wild-type TEPM, is not signi®cantly altered in the presence of IL-10 (±IL-10: 3.0 + 0.1; +IL-10: 2.5 + 0.70; n = 3) ( Figure 6B ). These observations demonstrate that MK2 is required for the ARE-dependent, IL-10-mediated inhibition of TNF production. p38/SAPK is activated predominantly by the MAP kinase kinases MKK3 and MKK6 (Raingeaud et al., 1996) . Although LPS-induced mkk3 ±/± macrophages Fig. 5 . IL-10 inhibits p38 phosphorylation in LPS-induced macrophages. TEPM and RAW 264.7 macrophages were challenged with LPS (1 mg/ml) and IL-10 (5ng/ml) for 15 min. Total cell lysates were immunoblotted with antibody probes for the phosphorylated forms of p38/SAPK (A) and JNK/SAPK (B). Membranes were stripped and reprobed for the detection of the total protein content of each kinase. Representative blots are shown. Quantitation of phospho-p38 kinase levels, normalized to the total p38 content, is also shown (A). Results from one out of three experiments, shown as mean densitometric units (+ SD) from independent cultures. (B) BMDM (5 3 10 5 adherent cells/ml) from wild-type (wt), TTP ±/± and Tnf DARE/+ BMDM were stimulated with LPS (1 mg/ml) for 12 h in the presence of various concentrations of IL-10 or SB203580; TNF levels in cultured supernatants were as before. Results shown as mean percentages of LPS values; data from at least three experiments with cells derived from individual mice (n = 5 mice/group/experiment).
IL-10 regulates TNF translation by controlling p38 MAPK
secrete normal quantities of TNF protein, a reduction in the general p38 activity was indicated in these cells, which could affect the IL-10-instigated inhibition of TNF production. Nevertheless, TNF production by LPS-stimulated mkk3 ±/± macrophages in the presence of IL-10 was similar to that of control cultures ( Figure 6C ), indicating that MKK3 is not involved in the inhibition of TNF translation by IL-10.
To verify whether inhibition of the p38 pathway is required for ef®cient IL-10 targeting of TNF production by macrophages, we transiently transfected the mouse macrophage cell line RAW 264.7 with a constitutively active form of MKK6, MKK6(Glu) (Raingeaud et al., 1996) . TNF translation by LPS-induced RAW 264.7 macrophages was affected by IL-10 in a manner similar to wild-type TEPM, as revealed by the corresponding cell fractionation studies ( Figure 6B ). Introduction of MKK6(Glu) into RAW 264.7 readily resulted in secretion of TNF (<2 ng), indicating functional interference of the exogenous MKK6(Glu) with TNF production (data not shown). However, LPS stimulation resulted in comparative values between MKK6(Glu) transfectants and controls. Most importantly, the ability of IL-10 to inhibit TNF production following LPS stimulation of RAW 264.7 was completely abrogated in the presence of MKK6(Glu) ( Figure 6D ). Overall, our results demonstrate that IL-10 interferes with the activation of the p38/MAPKAP-2 pathway to inhibit the ARE-dependent TNF translation in mouse macrophages.
Discussion
In this study, we show that IL-10-mediated signals primarily target TNF mRNA translation. This process is clearly dependent on TNF 3¢ARE, since in its absence the ef®cacy of IL-10 in inhibiting TNF expression is severely compromised. However, we failed to detect any effect of IL-10 on TNF mRNA decay, either in the presence or absence of TNF ARE, suggesting that TNF mRNA stability may not be targeted by IL-10 in macrophages. Our data seem different from previous reports suggesting that IL-10 leads to ARE-dependent destabilization of granulocyte±macrophage colony-stimulating factor, granulocyte colony-stimulating factor and KC cytokine mRNAs (Brown et al., 1996; Kishore et al., 1999) . This variance indicates differential properties imposed by the AREs on different mRNAs. Several additional observations support a functional separation between TNF 3¢ARE-mediated modulation of translation and stability. Pharmacological inhibition of p38/MAPK affects TNF mRNA translation by inhibiting LPS-induced polysome coupling of TNF mRNA in macrophages, without affecting TNF mRNA accumulation (Prichett et al., 1995) . Similarly, the absence of MK2 leads to a profound reduction of LPS-induced TNF production, yet TNF mRNA accumulation and stability are not affected (Kotlyarov et al., 1999) . Thirdly, and most importantly, TTP (a TNF ARE binding protein regulating TNF biosynthesis) exerts a potent destabilizing activity on TNF mRNA (Carballo et al., 1998; Lai et al., 1999) without imposing translational control (present data). These observations are important in conceptualizing independent pathways of ARE-mediated translational and stability controls being exerted, presumably, by different ARE binding complexes and associated signals. Two RNA binding proteins that have recently been demonstrated to have TNF ARE binding capacities are TIAR and TIA-1 (Gueydan et al., 1999; Piecyk et al., 2000) . Genetic ablation of TIA-1 leads to increased LPSinduced translation of TNF mRNA without affecting its abundance, making TIA-1 a putatively speci®c translational modulator.
Our results indicate that IL-10 interferes with the activation potential of the p38/MAPK pathway, which is required to activate TNF translation, as suggested by the MK2-de®cient macrophages and by the MKK6 (Glu) transfection assays. The reduction in the phosphorylated form of p38 following IL-10 treatment of macrophages indicates that IL-10 inhibits upstream of p38 activation. However, IL-10 still affects TNF production in MKK3-de®cient macrophages, in which a reduction in p38 activation was also noted (Lu et al., 1999) , indicating that MKK3 is not required. The most likely alternative could be that IL-10 interferes with the MKK6 signals activating p38 MAPK; however, in the absence of the corresponding de®cient mouse, we can only hypothesize on such a mechanism. Previous reports have provided controversial results on the effect of IL-10 on p38/SAPK (reviewed by Donelly et al., 1999) . Furthermore, earlier studies point towards a role for p38 in modulating the stability of TNF mRNA (Wang et al., 1999; Brook et al., 2000) . Our prediction is that the differences described in the literature result from different experimental conditions and systems utilized in each case. For example, in most previous reports, macrophages were pre-treated with IL-10 for at least 2 h prior to LPS stimulation. Under conditions of cytokine pre-treatment, however, altered responses have been reported to occur (Erwig et al., 1998) . We selected to co-administer LPS and IL-10 since IL-10 production is concomitant with or consecutive to LPSinduced TNF production in mouse macrophages (Figure 1) , and thus IL-10 pre-treatment of these cells may not be physiologically relevant. Finally, from the current data, we cannot exclude the possibility that other MAPK/SAPKmediated signals may also be utilized for the maximal effect of IL-10 towards TNF. However, since the activation of the JNK and ERK pathways is not being affected by IL-10, it is currently unclear how these pathways may interfere.
The detailed mechanism by which IL-10 targets MAPK/ SAPK signals is currently unknown. It is possible that IL-10 signaling interferes directly with the activation of MAPKs. Engagement of the IL-10 receptor (IL-10R) has been shown to activate the JAK±STAT pathway. Speci®cally, IL-10R signaling requires the activation of Jak1 and Tyk2, and induces the activation of Stat1, Stat3 and Stat5 (Riley et al., 1999) . There is evidence that points towards the requirement for Jak-1/STAT3 in TNF suppression (Riley et al., 1999; Takeda et al., 1999) . Thus, one possibility would be that STAT3 activates factors capable of interfering with MAPK/SAPK signaling. One such example has been provided by the STAT3-dependent inhibition of in¯ammatory signals through the activation of SOCS-3 (Bode et al., 1999; Cassatella et al., 1999; Levings and Schrader, 1999; Turkson et al., 1999; Schmitz et al., 2000) . However, since inhibition of p38/MAPK by IL-10 occurs very early (i.e. at 15 min), it is dif®cult to conceptualize a STAT3-dependent mechanism that would require de novo protein synthesis, e.g. of SOCS proteins. Interestingly, both STAT3 and SOCS3 can be activated by in¯ammatory stimuli like LPS and TNF and, most importantly, SOCS3 activation can be induced by STAT3-independent mechanisms (Stoiber et al., 1999; Ahmed and Ivashkiv, 2000) . In addition, LPS can synergize with IL-10 to prolong SOCS3 mRNA stability in myeloid cells (Cassatella et al., 1999) . Therefore, early post-transcriptional mechanisms may provide a pool of SOCS-3, which can be rapidly activated in the absence of de novo gene transcription. Consequently, SOCS-3 transcription may allow for the replenishment of a SOCS-3 pool to enforce its negative action in a temporal manner. This may also provide an answer on the seeming paradox of p38/MAPK dependency of both STAT3 and SOCS3 for their activation as well as for the apparent capacity of SOCS3 to suppress STAT3 activation itself (Ahmed and Ivashkiv, 2000; Suzuki et al., 2001) . Taken together, this evidence points towards a complex temporal regulation of these factors, which will eventually tune, in a timely manner, the pro-and anti-in¯ammatory signals. Figure 7 summarizes the possible interactions of IL-10R signaling to modules affecting activation of TNF gene expression.
The functional signi®cance of the current work is perhaps most convincingly exempli®ed by the pathologies developing in the models of compromised TNF modulation by IL-10R. Tnf DARE mice, as well as IL-10-and myeloid-speci®c STAT3-de®cient mice, develop overt in¯ammatory pathologies in the intestine, indicating a bias IL-10 regulates TNF translation by controlling p38 MAPK towards pro-in¯ammatory/immune-activating action. In addition, it has recently been demonstrated that inhibition of SOCS-3 activation in transgenic mice renders them more susceptible to a model of induced colitis (Suzuki et al., 2001) , verifying its potential to control in¯amma-tion. As demonstrated herein, TNF is required to a major extent for the development of IBD in IL-10-de®cient mice. Our results may seem in contrast with earlier observations that anti-TNF treatment of IL-10-de®cient mice was inef®cient in controlling IBD in this model (Rennick et al., 1997) . This discrepancy may re¯ect a developmental requirement for TNF in the pathology in the IL-10-de®cient mice. Our current data provide mechanistic clues as to how the IL-10/TNF axis may be deviated in the course of mutations affecting the function of TNF AREmediated controls, and demonstrate that a homeostatic cross-talk between IL-10 and TNF is essential in preventing immune dysregulation and disease.
Materials and methods

Mice
Il-10 ±/± (Kuhn et al., 1993) , Tnf ±/± (Pasparakis et al., 1996) , Tnf DARE/+ , Tnf DARE/DA Â RE TnfRI ±/± , TTP ±/± (Taylor et al., 1996) , mk2 ±/± (Kotlyarov et al., 1999) and mkk3 ±/± (Lu et al., 1999 ) mutant mice were bred and maintained on a C57BL/6J or a mixed C57BL/ 6J3129SvEm genetic background. All mice were housed under speci®c pathogen-free (SPF) conditions.
Histopathological evaluation
Paraf®n-embedded colon sample tissues were sectioned and stained with hematoxylin and eosin. In¯ammation in each region of the colon was graded semiquantitatively from 0 to 5 in a blinded fashion, using the following criteria: (0) no signs of in¯ammation to (5) most severe change including maximal degree of transmural in¯ammation, goblet cell loss, crypt abscesses and ulceration, and lamina propria ®brosis. The total disease score per mouse is calculated by the summation of the score for each segment of the colon, from 0 to 20, where 0 is no change, >0±5 is mild disease, >5±10 is moderate disease and >10±20 is severe disease. Data are represented as mean 6 SD.
Cell isolation and culture All cultures were grown and maintained at 37°C in 5% CO 2 . TEPM were isolated by peritoneal lavage from <10-week-old mice, 3 days after a single peritoneal injection of aged 4% thioglycolate broth (1 ml; Difco Laboratories). Cells were left to adhere for 1 h in Petri dishes, and washed and covered with fresh medium. TEPM cultures were left to rest for 4 h prior to experimentation. The ex vivo derivation of BMDM was performed as previously described . For all macrophage experiments, cells were seeded at a density of 5 3 10 5 cells/ well in 24-well tissue culture plates. Following resting, cultures were incubated in the presence or absence of the indicated quantities of LPS (Salmonella enteriditis; Sigma; L-6011), recombinant mouse IL-10 (R&D) or the p38 inhibitor SB203580 (Calbiochem) in RPMI + 5% fetal calf serum (Gibco).
TNF ELISA and NO detection assay Mouse TNF and IL-10 levels in sera and supernatants were determined using a sandwich TNF and IL-10 (R&D) ELISAs. To evaluate NO, NO 3 ± and NO 2 ± were measured from cell culture supernatants using Griess's assay (Green et al., 1982) .
FACS analysis: detection of tmTNF TEPM were washed extensively in phosphate-buffered saline (PBS) + 0.1% bovine serum albumin + 0.01% sodium azide (PBA) and saturated with blocking buffer (PBA + 5% normal rabbit serum). Cells were incubated with biotinylated rabbit anti-mouse and -rat TNF polyclonal antibodies (PharMingen), followed by incubation with streptavidin±phycoerythrin (PharMingen). Subsequently, cells were ®xed with 4% paraformaldehyde for 10 min at 4°C and analyzed with a FACSCaliburÔ cytometer.
Cell fractionation and polysome analysis Macrophages were collected and maintained as described above in 10 cm plates. LPS (1 mg/ml) in the absence or presence of IL-10 (5 ng/ml) was added for 2 h. Cells were washed in ice-cold PBS containing 150 mg/ml cyclohexamide and collected into 1.0 ml of cold hypotonic lysis buffer (10 mM KCl, 10 mM Tris pH 7.2, 10 mM MgCl 2 , 20 mM dithiothreitol, 150 mg/ml cycloheximide, 0.5 mg/ml heparin, 0.5% NP-40 and 100 U/ml RNasin) and mechanically disrupted by douncing. Nuclei and cell membranes were removed by microcentrifugation for 10 min. The supernatant was layered onto a 10±50% continuous sucrose gradient. Centrifugation was performed at 27 000 r.p.m. for 3 h using a SW27Ti rotor. Fractions (2 ml) were collected, starting from the top of the gradient, and UV absorbance was monitored at 254 nm to identify fractions containing monosomes and polysomes. Samples of total RNA were extracted with phenol/chloroform from each fraction, ethanol precipitated and resuspended in 30 ml of diethyl pyrocarbonate-treated ddH 2 O. Ten microliters of each sample were mixed with 20 ml of formamide, 7 ml of formaldehyde (37%) and 2 ml of 203 SSC, and applied to a nitrocellulose membrane using a dot-blot apparatus. Following hybridization, the relative amounts of 32 P-labeled TNF and GAPDH mRNAs in each fraction were determined using a Storm phosphoimager.
Cell transfections RAW 264.7 macrophages were grown and maintained in RPMI medium containing 5% fetal bovine serum at 37°C in 5% CO 2 . Cells were transfected by electroporation using a Bio-Rad Gene PulserÔ as previously described (Thompson et al., 1999) . Brie¯y, cells were washed extensively in PBS. Cells (5 3 10 6 ) were then mixed with 5 mg of the expression plasmid for constitutively active MKK6(Glu) (Raingaud et al., 1996) , or the control plasmid pGFP (Clontech, USA), into a ®nal volume of 400 ml. Cells were incubated on ice for 10 min and then pulsed into 0.4 cm cuvettes at 260 V and 960 mF. Transfected cells were split into the desired number of plates to recover and adhere for 2 h, washed, and left to rest for 18 h. Transfection ef®ciency was veri®ed using FACS analysis using a FACScan cytometer (Becton & Dickinson) for the detection of green¯uorescent protein (GFP). Maximal GFP expression was detected at 24 h (~70%), reducing to 30±40% at 48 h. The plates were then stimulated at 20 h with LPS (1 mg/ml), with or without the indicated quantities of IL-10, and incubated for 12 h. Cell survival was assessed via crystal violet staining (0.5%) for the cytokine production assays. Supernatants were harvested as previously described and used immediately for TNF ELISA.
Immunoblotting and RNA analysis For western analysis, the probes used were monoclonal antibodies for p38a/b (A-12) and JNK1/2 (D-2), as well as polyclonal antibodies for the phosphorylated forms of JNK [speci®c for Thr-(P)-183 and Tyr-(P)-185 of human JNK1 & 2] and p38 [speci®c for Tyr-(P)-182 of human p38]. All antibodies were purchased from Santa Cruz Biotechnologies. For northern analysis of RNA samples, a 0.9 kb NarI±BglII genomic probe containing part of the ®rst exon of mTNF gene was used. A 0.9 kb mouse PstI b-actin fragment was used as a quantitative control.
Statistics
Fisher's exact test for non-parametric data for statistical signi®cance was used to compare results between different populations of mice. The unpaired Student's t-test for statistical signi®cance was used to compare protein and mRNA values.
